Skip to content

688089.SH

ST嘉必优

SSE · Healthcare · Biotechnology · CN

CNY 7.56
+0.67%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue418.2M563.1M555.6M443.8M433.4M
Cost of Revenue236.7M294.5M313.3M255.6M250.8M
Gross Profit181.5M268.6M242.3M188.2M182.7M
Operating Expenses
R&D Expense48.7M47.4M47.9M38.6M32.3M
SG&A Expense
General & Admin Expense46.6M43.7M40.5M25.9M39.5M
Selling & Marketing Expense23.2M24.4M31.8M30.4M24.8M
Other Expenses
Total Operating Expenses128.1M120.6M121.6M98.9M85.9M
Cost and Expenses364.8M415.1M434.9M354.5M336.6M
Operating Income (EBIT)56.0M149.5M126.5M81.6M51.1M
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)65.4M162.3M139.8M100.0M78.1M
Income Tax Expense15.7M23.0M19.7M13.6M16.6M
Bottom Line
Net Income55.2M143.7M124.2M91.4M64.4M
Earnings from Cont. Ops49.8M139.3M120.1M86.4M61.6M
Earnings from Discont. Ops
Bottom Line Net Income55.2M143.7M124.2M91.4M64.4M
Per Share
Basic EPSCN¥0.33CN¥0.86CN¥0.74CN¥0.54CN¥0.38
Diluted EPSCN¥0.33CN¥0.86CN¥0.74CN¥0.54CN¥0.38
Revenue Per ShareCN¥2.50CN¥3.37CN¥3.31CN¥2.62CN¥2.56
Shares
Basic Shares Outstanding167.6M167.1M167.9M169.2M169.4M
Diluted Shares Outstanding167.6M167.1M167.9M169.2M169.4M
Profitability Metrics
EBITDA212.5M183.9M130.4M77.7M
D&A63.0M57.4M48.8M26.6M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026